feed,title,long_url,short_url
Investing,Earnings call: Intrusion Inc. reports Q1 2024 results and optimistic outlook,https://www.investing.com/news/stock-market-news/earnings-call-intrusion-inc-reports-q1-2024-results-and-optimistic-outlook-93CH-3441959,https://da.gd/tqJs4k
Investing,Earnings call: Pixelworks reports growth and confidence despite challenges,https://www.investing.com/news/stock-market-news/earnings-call-pixelworks-reports-growth-and-confidence-despite-challenges-93CH-3441947,https://da.gd/vJWECC
Investing,Earnings call: VolitionRx targets profitability with strategic cost cuts,https://www.investing.com/news/stock-market-news/earnings-call-volitionrx-targets-profitability-with-strategic-cost-cuts-93CH-3441946,https://da.gd/L8Rx
Investing,Earnings call: Oxford Lane Capital Corp. reports Q4 fiscal 2024 results,https://www.investing.com/news/stock-market-news/earnings-call-oxford-lane-capital-corp-reports-q4-fiscal-2024-results-93CH-3441945,https://da.gd/oS22H
Investing,"Earnings call: Nuvve reports Q1 revenue decline, optimistic outlook",https://www.investing.com/news/stock-market-news/earnings-call-nuvve-reports-q1-revenue-decline-optimistic-outlook-93CH-3441944,https://da.gd/tr4aKd
Investing,Earnings call: NeuroOne reports growth and strategic progress in Q2,https://www.investing.com/news/stock-market-news/earnings-call-neuroone-reports-growth-and-strategic-progress-in-q2-93CH-3441943,https://da.gd/pJH3Yh
Investing,"Earnings call: SoundThinking reports robust Q1 growth, reaffirms 2024 outlook",https://www.investing.com/news/stock-market-news/earnings-call-soundthinking-reports-robust-q1-growth-reaffirms-2024-outlook-93CH-3441933,https://da.gd/gm7k
Investing,Earnings call: SKYX Platforms Q1 2024 sales rise as it eyes standardization,https://www.investing.com/news/stock-market-news/earnings-call-skyx-platforms-q1-2024-sales-rise-as-it-eyes-standardization-93CH-3441932,https://da.gd/noh7pq
Investing,Earnings call: Cyclacel Pharmaceuticals reports Q1 2024 results,https://www.investing.com/news/stock-market-news/earnings-call-cyclacel-pharmaceuticals-reports-q1-2024-results-93CH-3441931,https://da.gd/kfJse
Investing,Earnings call: Cemtrex reports mixed Q2 2024 results amid growth efforts,https://www.investing.com/news/stock-market-news/earnings-call-cemtrex-reports-mixed-q2-2024-results-amid-growth-efforts-93CH-3441930,https://da.gd/X9NaoZ
